期刊文献+

血小板对肝癌发生、发展及治疗影响的研究进展

Research Progress on the Impact of Platelets on the Occurrence, Development, and Treatment of Liver Cancer
下载PDF
导出
摘要 本文全面回顾了血小板在肝癌发生、发展及治疗中的作用。肝细胞癌(Hepatocellular Carcinoma, HCC)是一种常见的恶性肿瘤,其发生、发展和转移涉及多种因素。研究表明,血小板在肝癌的肿瘤微环境中发挥关键作用,并在诊断和治疗中具有潜在价值。我们探讨了血小板在肝纤维化、肝癌细胞增殖及转移和肝脏手术后再生中的作用。此外,还讨论了抗血小板疗法在预防肝癌复发方面的有效性及其可能的风险,旨在为肝癌治疗提供全面的治疗策略。 This article comprehensively reviews the role of platelets in the occurrence, development, and treatment of hepatocellular carcinoma (Hepatocellular Carcinoma, HCC). HCC, a common malignant tumor, involves various factors in its development, progression, and metastasis. The study high-lights the critical role of platelets in the tumor microenvironment of liver cancer and their potential value in diagnosis and treatment. It discusses the involvement of platelets in liver fibrosis, prolifer-ation of liver cancer cells, metastasis, and liver regeneration post-surgery. Additionally, the article examines the effectiveness and potential risks of antiplatelet therapy in preventing the recurrence of liver cancer, aiming to provide comprehensive treatment strategies for liver cancer.
出处 《临床医学进展》 2024年第3期541-546,共6页 Advances in Clinical Medicine
  • 相关文献

参考文献1

二级参考文献22

  • 1A. K. Singal,H. Salameh,Y.‐F. Kuo,R. J. Fontana.Meta‐analysis: the impact of oral anti‐viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B[J]. Aliment Pharmacol Ther . 2013 (2) 被引量:1
  • 2Yun-Fan Liaw.Impact of Therapy on the Long-Term Outcome of Chronic Hepatitis B[J]. Clinics in Liver Disease . 2013 被引量:1
  • 3Shih-Cheng Yang,Chuan-Mo Lee,Tsung-Hui Hu,Jing-Houng Wang,Sheng-Nan Lu,Chao-Hung Hung,Chi-Sin Changchien,Chien-Hung Chen.Virological response to entecavir reduces the risk of liver disease progression in nucleos(t)ide analogue-experienced HBV-infected patients with prior resistant mutants[J]. Journal of Antimicrobial Chemotherapy . 2013 (9) 被引量:1
  • 4Francesca Guerrieri,Laura Belloni,Natalia Pediconi,Massimo Levrero.Molecular Mechanisms of HBV-Associated Hepatocarcinogenesis[J]. Semin Liver Dis . 2013 (02) 被引量:1
  • 5S.S. Kim,S.J. Ahn,S.Y. Park,G.W. Song,J.Y. Cheong,S.W. Cho.652 VIROLOGICAL RESPONSE TO ENTECAVIR IS ASSOCIATED WITH LOW PROBABILITY OF DEVELOPING HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS WITH CIRRHOSIS[J]. Journal of Hepatology . 2013 被引量:1
  • 6W.R. Kim,T. Berg,R. Loomba,R. Aguilar Schall,P. Dinh,L.J. Yee,E.B. Martins,J.F. Flaherty,S. Gurel,M. Buti,P. Marcellin.43 LONG TERM TENOFOVIR DISOPROXIL FUMARATE (TDF) THERAPY AND THE RISK OF HEPATOCELLULAR CARCINOMA[J]. Journal of Hepatology . 2013 被引量:1
  • 7G. L.‐H. Wong,H. L.‐Y. Chan,K. K.‐L. Yiu,J. W.‐Y. Lai,V. K.‐K. Chan,K. K.‐C. Cheung,E. W.‐N. Wong,V. W.‐S. Wong.Meta‐analysis: the association of hepatitis B virus genotypes and hepatocellular carcinoma[J]. Aliment Pharmacol Ther . 2013 (5) 被引量:1
  • 8European Association for the Study of the Liver.EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection[J]. Journal of Hepatology . 2012 (1) 被引量:1
  • 9Alejandro Forner,Josep M Llovet,Jordi Bruix.Hepatocellular carcinoma[J]. The Lancet . 2012 (9822) 被引量:1
  • 10Mika Kurokawa,Naoki Hiramatsu,Tsugiko Oze,Takayuki Yakushijin,Masanori Miyazaki,Atsushi Hosui,Takuya Miyagi,Yuichi Yoshida,Hisashi Ishida,Tomohide Tatsumi,Shinichi Kiso,Tatsuya Kanto,Akinori Kasahara,Sadaharu Iio,Yoshinori Doi,Akira Yamada,Masahide Oshita,Akira Kaneko,Kiyoshi Mochizuki,Hideki Hagiwara,Eiji Mita,Toshifumi Ito,Yoshiaki Inui,Kazuhiro Katayama,Harumasa Yoshihara,Yasuharu Imai,Eijirou Hayashi,Norio Hayashi,Tetsuo Takehara.Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection[J]. Journal of Gastroenterology . 2012 (5) 被引量:1

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部